APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sartans

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Sartans Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025192 pages

Choose your research edition.

Industry ResearchSartans Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Sartans Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Sartans Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sartans Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Sartans Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Sartans market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Sartans is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Sartans is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sartans is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Sartans is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sartans include Teva Pharmaceutical, Sanofi, Jhonson and Johnson, Novartis, Merck, Eli Lilly, Pfizer, GSK and Bayer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Sartans market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Sartans and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Sartans sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Sartans market size, projected growth trends, production technologies, key applications, and end-use industries.

Sartans Segment by Company

Teva Pharmaceutical

Sanofi

Jhonson and Johnson

Novartis

Merck

Eli Lilly

Pfizer

GSK

Bayer

Bristol-Myers Squibb

Astra Zeneca

Sartans Segment by Type

Valsartan

Telmisartan

Losartan

Irbesartan

Olmesartan

Azilsartan

Sartans Segment by Application

Cardiovascular Diseases

Kidney Diseases

Hypertension

Other

Sartans Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sartans market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sartans and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sartans.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Sartans market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sartans manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Sartans in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Sartans in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Sartans Industry Trends Table 2. Sartans Industry Drivers Table 3. Sartans Industry Opportunities and Challenges Table 4. Sartans Industry Restraints Table 5. Global Sartans Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Sartans Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Sartans Sales by Manufacturers (k tons) & (2021-2026) Table 8. Global Sartans Sales Market Share by Manufacturers Table 9. Global Sartans Average Sales Price (US$/ton) of Manufacturers (2021-2026) Table 10. Global Sartans Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Sartans Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Sartans Manufacturers, Product Type & Application Table 13. Global Sartans Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Sartans by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Valsartan Table 17. Major Manufacturers of Telmisartan Table 18. Major Manufacturers of Losartan Table 19. Major Manufacturers of Irbesartan Table 20. Major Manufacturers of Olmesartan Table 21. Major Manufacturers of Azilsartan Table 22. Global Sartans Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 23. Global Sartans Sales by Type (2021-2026) & (k tons) Table 24. Global Sartans Sales by Type (2027-2032) & (k tons) Table 25. Global Sartans Sales Market Share by Type (2021-2026) Table 26. Global Sartans Sales Market Share by Type (2027-2032) Table 27. Global Sartans Revenue by Type 2021 VS 2025 VS 2032 (k tons) Table 28. Global Sartans Revenue by Type (2021-2026) & (k tons) Table 29. Global Sartans Revenue by Type (2027-2032) & (k tons) Table 30. Global Sartans Revenue Market Share by Type (2021-2026) Table 31. Global Sartans Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Cardiovascular Diseases Table 33. Major Manufacturers of Kidney Diseases Table 34. Major Manufacturers of Hypertension Table 35. Major Manufacturers of Other Table 36. Global Sartans Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 37. Global Sartans Sales by Application (2021-2026) & (k tons) Table 38. Global Sartans Sales by Application (2027-2032) & (k tons) Table 39. Global Sartans Sales Market Share by Application (2021-2026) Table 40. Global Sartans Sales Market Share by Application (2027-2032) Table 41. Global Sartans Revenue by Application 2021 VS 2025 VS 2032 (k tons) Table 42. Global Sartans Revenue by Application (2021-2026) & (k tons) Table 43. Global Sartans Revenue by Application (2027-2032) & (k tons) Table 44. Global Sartans Revenue Market Share by Application (2021-2026) Table 45. Global Sartans Revenue Market Share by Application (2027-2032) Table 46. Global Sartans Sales by Region: 2021 VS 2025 VS 2032 (k tons) Table 47. Global Sartans Sales by Region (2021-2026) & (k tons) Table 48. Global Sartans Sales Market Share by Region (2021-2026) Table 49. Global Sartans Sales Forecasted by Region (2027-2032) & (k tons) Table 50. Global Sartans Sales Forecasted Market Share by Region (2027-2032) Table 51. North America Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 52. North America Sartans Sales by Country (2021-2026) & (k tons) Table 53. North America Sartans Sales by Country (2027-2032) & (k tons) Table 54. Europe Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 55. Europe Sartans Sales by Country (2021-2026) & (k tons) Table 56. Europe Sartans Sales by Country (2027-2032) & (k tons) Table 57. Asia Pacific Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 58. Asia Pacific Sartans Sales by Country (2021-2026) & (k tons) Table 59. Asia Pacific Sartans Sales by Country (2027-2032) & (k tons) Table 60. South America, Middle East and Africa Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k tons) Table 61. South America, Middle East and Africa Sartans Sales by Country (2021-2026) & (k tons) Table 62. South America, Middle East and Africa Sartans Sales by Country (2027-2032) & (k tons) Table 63. Global Sartans Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 64. Global Sartans Revenue by Region (2021-2026) & (US$ Million) Table 65. Global Sartans Revenue by Region (2027-2032) & (US$ Million) Table 66. Global Sartans Revenue Market Share by Region (2021-2026) Table 67. Global Sartans Revenue Market Share by Region (2027-2032) Table 68. Teva Pharmaceutical Company Information Table 69. Teva Pharmaceutical Business Overview Table 70. Teva Pharmaceutical Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Teva Pharmaceutical Sartans Product Portfolio Table 72. Teva Pharmaceutical Recent Development Table 73. Sanofi Company Information Table 74. Sanofi Business Overview Table 75. Sanofi Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Sanofi Sartans Product Portfolio Table 77. Sanofi Recent Development Table 78. Jhonson and Johnson Company Information Table 79. Jhonson and Johnson Business Overview Table 80. Jhonson and Johnson Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Jhonson and Johnson Sartans Product Portfolio Table 82. Jhonson and Johnson Recent Development Table 83. Novartis Company Information Table 84. Novartis Business Overview Table 85. Novartis Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Novartis Sartans Product Portfolio Table 87. Novartis Recent Development Table 88. Merck Company Information Table 89. Merck Business Overview Table 90. Merck Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Merck Sartans Product Portfolio Table 92. Merck Recent Development Table 93. Eli Lilly Company Information Table 94. Eli Lilly Business Overview Table 95. Eli Lilly Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Eli Lilly Sartans Product Portfolio Table 97. Eli Lilly Recent Development Table 98. Pfizer Company Information Table 99. Pfizer Business Overview Table 100. Pfizer Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Pfizer Sartans Product Portfolio Table 102. Pfizer Recent Development Table 103. GSK Company Information Table 104. GSK Business Overview Table 105. GSK Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. GSK Sartans Product Portfolio Table 107. GSK Recent Development Table 108. Bayer Company Information Table 109. Bayer Business Overview Table 110. Bayer Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bayer Sartans Product Portfolio Table 112. Bayer Recent Development Table 113. Bristol-Myers Squibb Company Information Table 114. Bristol-Myers Squibb Business Overview Table 115. Bristol-Myers Squibb Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Bristol-Myers Squibb Sartans Product Portfolio Table 117. Bristol-Myers Squibb Recent Development Table 118. Astra Zeneca Company Information Table 119. Astra Zeneca Business Overview Table 120. Astra Zeneca Sartans Sales (k tons), Price (US$/ton), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Astra Zeneca Sartans Product Portfolio Table 122. Astra Zeneca Recent Development Table 123. Key Raw Materials Table 124. Raw Materials Key Suppliers Table 125. Sartans Distributors List Table 126. Sartans Customers List Table 127. Research Programs/Design for This Report Table 128. Authors List of This Report Table 129. Secondary Sources Table 130. Primary Sources List of Figures Figure 1. Sartans Product Image Figure 2. Global Sartans Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sartans Market Size (2021-2032) & (US$ Million) Figure 4. Global Sartans Sales (2021-2032) & (k tons) Figure 5. Global Sartans Average Price (US$/ton) & (2021-2032) Figure 6. Global Top 5 and 10 Sartans Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Valsartan Image Figure 9. Telmisartan Image Figure 10. Losartan Image Figure 11. Irbesartan Image Figure 12. Olmesartan Image Figure 13. Azilsartan Image Figure 14. Global Sartans Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 15. Global Sartans Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Sartans Sales Market Share by Type (2021-2032) Figure 17. Global Sartans Revenue by Type (2021 VS 2025 VS 2032) & (k tons) Figure 18. Global Sartans Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Sartans Revenue Market Share by Type (2021-2032) Figure 20. Cardiovascular Diseases Image Figure 21. Kidney Diseases Image Figure 22. Hypertension Image Figure 23. Other Image Figure 24. Global Sartans Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 25. Global Sartans Sales Market Share 2021 VS 2025 VS 2032 Figure 26. Global Sartans Sales Market Share by Application (2021-2032) Figure 27. Global Sartans Revenue by Application (2021 VS 2025 VS 2032) & (k tons) Figure 28. Global Sartans Revenue Market Share 2021 VS 2025 VS 2032 Figure 29. Global Sartans Revenue Market Share by Application (2021-2032) Figure 30. North America Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 31. North America Sartans Sales Market Share by Country (2021-2032) Figure 32. U.S. Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 33. Canada Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 34. Mexico Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 35. Europe Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 36. Europe Sartans Sales Market Share by Country (2021-2032) Figure 37. Germany Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 38. France Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 39. U.K. Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 40. Italy Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 41. Netherlands Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 42. Asia Pacific Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 43. Asia Pacific Sartans Sales Market Share by Country (2021-2032) Figure 44. China Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 45. Japan Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 46. South Korea Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 47. Southeast Asia Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 48. India Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 49. Australia Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 50. South America, Middle East and Africa Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 51. South America, Middle East and Africa Sartans Sales Market Share by Country (2021-2032) Figure 52. Brazil Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 53. South Africa Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 54. Saudi Arabia Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 55. Turkey Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 56. Argentina Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 57. UAE Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 58. Egypt Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 59. Chile Sartans Sales and Growth Rate (2021-2032) & (k tons) Figure 60. Global Sartans Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Global Sartans Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 62. North America Sartans Revenue (2021-2032) & (US$ Million) Figure 63. North America Sartans Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Europe Sartans Revenue (2021-2032) & (US$ Million) Figure 65. Europe Sartans Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Asia-Pacific Sartans Revenue (2021-2032) & (US$ Million) Figure 67. Asia-Pacific Sartans Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. South America, Middle East and Africa Sartans Revenue (2021-2032) & (US$ Million) Figure 69. South America, Middle East and Africa Sartans Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. Sartans Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Sartans Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Valsartan
  • Telmisartan
  • Losartan
  • Irbesartan
  • Olmesartan
  • Azilsartan
Applications
  • Cardiovascular Diseases
  • Kidney Diseases
  • Hypertension
  • Other
Companies covered
  • Teva Pharmaceutical
  • Sanofi
  • Jhonson and Johnson
  • Novartis
  • Merck
  • Eli Lilly
  • Pfizer
  • GSK
  • Bayer
  • Bristol-Myers Squibb
  • Astra Zeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Sartans Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Sartans Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Sartans Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Sartans Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Sartans Market Dynamics
  1. 2.1 Sartans Industry Trends
  2. 2.2 Sartans Industry Drivers
  3. 2.3 Sartans Industry Opportunities and Challenges
  4. 2.4 Sartans Industry Restraints
3 Sartans Market by Manufacturers
  1. 3.1 Global Sartans Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Sartans Sales by Manufacturers (2021-2026)
  3. 3.3 Global Sartans Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Sartans Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sartans Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Sartans Manufacturers, Product Type & Application
  7. 3.7 Global Sartans Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sartans Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sartans Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sartans Tier 1, Tier 2, and Tier 3
4 Sartans Market by Type
  1. 4.1 Sartans Type Introduction
  2. 4.1.1 Valsartan
  3. 4.1.2 Telmisartan
  4. 4.1.3 Losartan
  5. 4.1.4 Irbesartan
  6. 4.1.5 Olmesartan
  7. 4.1.6 Azilsartan
  8. 4.2 Global Sartans Sales by Type
  9. 4.2.1 Global Sartans Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Sartans Sales by Type (2021-2032)
  11. 4.2.3 Global Sartans Sales Market Share by Type (2021-2032)
  12. 4.3 Global Sartans Revenue by Type
  13. 4.3.1 Global Sartans Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Sartans Revenue by Type (2021-2032)
  15. 4.3.3 Global Sartans Revenue Market Share by Type (2021-2032)
5 Sartans Market by Application
  1. 5.1 Sartans Application Introduction
  2. 5.1.1 Cardiovascular Diseases
  3. 5.1.2 Kidney Diseases
  4. 5.1.3 Hypertension
  5. 5.1.4 Other
  6. 5.2 Global Sartans Sales by Application
  7. 5.2.1 Global Sartans Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Sartans Sales by Application (2021-2032)
  9. 5.2.3 Global Sartans Sales Market Share by Application (2021-2032)
  10. 5.3 Global Sartans Revenue by Application
  11. 5.3.1 Global Sartans Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Sartans Revenue by Application (2021-2032)
  13. 5.3.3 Global Sartans Revenue Market Share by Application (2021-2032)
6 Global Sartans Sales by Region
  1. 6.1 Global Sartans Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Sartans Sales by Region (2021-2032)
  3. 6.2.1 Global Sartans Sales by Region (2021-2026)
  4. 6.2.2 Global Sartans Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Sartans Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Sartans Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Sartans Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Sartans Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Sartans Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Sartans Revenue by Region
  1. 7.1 Global Sartans Revenue by Region
  2. 7.1.1 Global Sartans Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Sartans Revenue by Region (2021-2026)
  4. 7.1.3 Global Sartans Revenue by Region (2027-2032)
  5. 7.1.4 Global Sartans Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Sartans Revenue (2021-2032)
  8. 7.2.2 North America Sartans Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Sartans Revenue (2021-2032)
  11. 7.3.2 Europe Sartans Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Sartans Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Sartans Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Sartans Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Sartans Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical
  2. 8.1.1 Teva Pharmaceutical Company Information
  3. 8.1.2 Teva Pharmaceutical Business Overview
  4. 8.1.3 Teva Pharmaceutical Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Sartans Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Sartans Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Jhonson and Johnson
  14. 8.3.1 Jhonson and Johnson Company Information
  15. 8.3.2 Jhonson and Johnson Business Overview
  16. 8.3.3 Jhonson and Johnson Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Jhonson and Johnson Sartans Product Portfolio
  18. 8.3.5 Jhonson and Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Sartans Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Sartans Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Eli Lilly
  32. 8.6.1 Eli Lilly Company Information
  33. 8.6.2 Eli Lilly Business Overview
  34. 8.6.3 Eli Lilly Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Eli Lilly Sartans Product Portfolio
  36. 8.6.5 Eli Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Sartans Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 GSK
  44. 8.8.1 GSK Company Information
  45. 8.8.2 GSK Business Overview
  46. 8.8.3 GSK Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 GSK Sartans Product Portfolio
  48. 8.8.5 GSK Recent Developments
  49. 8.9 Bayer
  50. 8.9.1 Bayer Company Information
  51. 8.9.2 Bayer Business Overview
  52. 8.9.3 Bayer Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bayer Sartans Product Portfolio
  54. 8.9.5 Bayer Recent Developments
  55. 8.10 Bristol-Myers Squibb
  56. 8.10.1 Bristol-Myers Squibb Company Information
  57. 8.10.2 Bristol-Myers Squibb Business Overview
  58. 8.10.3 Bristol-Myers Squibb Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bristol-Myers Squibb Sartans Product Portfolio
  60. 8.10.5 Bristol-Myers Squibb Recent Developments
  61. 8.11 Astra Zeneca
  62. 8.11.1 Astra Zeneca Company Information
  63. 8.11.2 Astra Zeneca Business Overview
  64. 8.11.3 Astra Zeneca Sartans Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Astra Zeneca Sartans Product Portfolio
  66. 8.11.5 Astra Zeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Sartans Value Chain Analysis
  2. 9.1.1 Sartans Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Sartans Production Mode & Process
  6. 9.2 Sartans Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Sartans Distributors
  9. 9.2.3 Sartans Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst